Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

Rhea-AI Summary

Seer, Inc. (Nasdaq: SEER) will report its financial results for Q4 and full year 2022 on March 2, 2023, after market close. A conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET, available via webcast on the Investor section of Seer’s website. Seer specializes in proteomics, offering the Proteograph Product Suite, which enables deep, unbiased proteomic analysis efficiently. This solution uses proprietary engineered nanoparticles and is designed for use in a variety of laboratory settings.

Positive

• Announcement of financial results reporting, indicating transparency.
• Innovative Proteograph Product Suite for proteomic analysis enhances market presence.

Negative

• None.

REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the fourth quarter and full year 2022, after market close, on Thursday, March 2, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.

About Seer
Seer™ is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio

FAQ

When will Seer report its financial results for 2022?

Seer will report its financial results for the fourth quarter and full year 2022 on March 2, 2023.

What time is the conference call scheduled for Seer’s financial results?

The conference call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on March 2, 2023.

Where can I listen to Seer's financial results webcast?

The webcast will be available on the Investor section of Seer’s website at investor.seer.bio.

What is the Proteograph Product Suite from Seer?

The Proteograph Product Suite is an integrated solution for deep proteomic analysis that includes engineered nanoparticles, automation instruments, and software.